The latest piece of evidence to confirm many of the revelations we’ve published for the past year or so. You have to read back to get more of the picture we’re about to sketch here.
We can’t offer informed consent for these experiments conducted on us because we are not offered much information. Only rich people can access some of it at prices most of us can’t dream. Maybe you can, or maybe people start donating enough so we can afford surviving another month and buying this info for the purpose of making it freely available to everyone, as it should be.
What am I talking about is the book pictured in our cover illustration and detailed below, which costs well over 1000$!
More precisely $1185 just for a single license PDF, the hardcover print would cost you about 100 more.
Why is this thing so expensive, you may ask?
THESE INFORMATIONS ARE SO EXPENSIVE EXACTLY TO BE PROHIBITIVE TO THE PLEBS AND OFFER A LEVERAGE OVER THOSE WHO ARE KEPT OUT OF THE LOOP, IN THE DARK
Predictably so, but:
These informations also must to have the highest degree of accuracy in order to sell as expensively!
Superb quality book delivered in a timely fashion with full financial documentation received via email.
Testimonial by Dr Tom Kidd, Associate Professor, University of Nevada
Bonus for us, this book is from May 2020, so it must have been elaborated prior to April 2020. This means it might be outdated by now for investors, but witty investigators like us find an advantage in this:
THE BOOK HAS BEEN ELABORATED WITH BEHIND THE SCENES SCIENCE ON THE INDUSTRIES WHICH, IN TURN MUST HAVE HAD PRE-SCIENCE ON THE PLANDEMIC!
There was no publicly available information in March to build such a book, and the industries they talk about must have been prescient, way ahead of the writers.
Only the fact that this book existed in May 2020 is single-handedly proving there was a whole lot of awareness in some industries about the pandemic.
Corroborated with all other evidence we’ve provided on this website, pandemic pre-planning, ergo pre-science, becomes a certitude.
Until plebs learn the GameStop lesson properly and start associating their financial power to break this classism and this information gatekeeping, we have to be happy with whatever meat we can chew from the bones they throw out.
Luckily for you, I can show you how to suck a bone dry and use it to find more.
It’s not going to be a full course, but it might become more than most people can load up.
Let’s start with the description (highlights are mine):
“Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic. This analysis examines in detail how nanotechnology and nanomaterials can help in the fight against this pandemic disease, and ongoing mitigation strategies. Nano-based products are currently being developed and deployed for the containment, diagnosis, and treatment of Covid-19.
Nanotechnology and nanomaterials promise:
- Improved and virus disabling air filtration.
- Low-cost, scalable detection methods for the detection of viral particles
- Enhanced personal protection equipment (PPE) including facemasks.
- New antiviral vaccine and drug delivery platforms.
- New therapeutic solutions.
Report contents include:
- Market analysis of nano-based diagnostic tests for COVID-19 including nanosensors incorporating gold nanoparticles, iron oxide nanoparticles, graphene, quantum dots, carbon quantum dots and carbon nanotubes. Market revenues adjusted to pandemic outcomes. In-depth company profiles. Companies profiled include Abbott Laboratories, Cardea, Ferrotec (USA) Corporation, E25Bio, Grolltex, Inc., Luminex Corporation etc.
- Market analysis of antiviral and antimicrobial nanocoatings for surfaces including fabric (mask, gloves, doctor coats, curtains, bed sheet), metal (lifts, doors handle, nobs, railings, public transport), wood (furniture, floors and partition panels), concrete (hospitals, clinics and isolation wards) and plastics (switches, kitchen and home appliances).
- Market revenues adjusted to pandemic outcomes. In-depth company profiles. Companies profiled include Advanced Materials-JTJ s.r.o., Bio-Fence, Bio-Gate AG, Covalon Technologies Ltd., EnvisionSQ, GrapheneCA, Integricote, Nano Came Co. Ltd., NanoTouch Materials, LLC, NitroPep and many more.
- Market analysis of air-borne virus filtration including photocatalytic Nano-TiO2 filters, nanofiber filers, nanosilver, nanocellulose, graphene and carbon nanotube filtration. Market revenues adjusted to pandemic outcomes. In-depth company profiles. Companies profiled include G6 Materials, Daicel FineChem Ltd., NANOVIA s.r.o., Toray Industries, Inc., Tortech Nano Fibers etc.
- Market analysis of nano-based facemask and other PPE products. Market revenues adjusted to pandemic outcomes. In-depth company profiles. Companies profiled include planarTECH LLC, RESPILON Group s. r. o., SITA, Sonovia Ltd. etc.
- Nanotherapies and drug delivery vehicles currently being produced and clinical trials of vaccines for COVID-19. Market revenues adjusted to pandemic outcomes. In-depth company profiles. In-depth company profiles. Companies profiled include Arcturus Therapeutics, Inc., Arbutus Biopharma, BlueWillow Biologics, Elastrin Therapeutics Inc., EnGeneIC Ltd. etc.
- Key scientific breakthroughs and developments that are underway right now.”
As you can see, the description alone offers enough evidence that embedding a whole range of nanotech in facemasks, tests, drugs and many other product.
You can bet your ass your new fridge connect to the internet and has some antimicrobial nanocoating that later will prove to be worse than DDT or asbestos, but at least it’s not gonna be Covid, right?
Can we dig more clues though?
Sir, yes, sir!
I’m going to do something unusual and seemingly unpractical copying here the whole table of contents, just in case, because almost every chapter and figure title deserves to be a separate post on this website as well, besides the multitude of leads as to what to research.
1 RESEARCH SCOPE AND METHODOLOGY
1.1 Report scope
1.2 Research methodology
3 DIAGNOSTIC TESTING
3.1 Nanotechnology and nanomaterials solutions
3.1.1 Current Diagnostic Tests for COVID-19
3.1.2 Emerging Diagnostic Tests for COVID-19
3.1.3 Nanosensors/nanoparticles (silver nanoclusters, Gold nanoparticles, Iron oxide nanoparticles, Quantum dot barcoding, nanowires, silica nanoparticles)
3.1.4 Carbon nanomaterials for diagnostic testing
3.2 Market revenues
3.2.1 Market estimates adjusted to pandemic demand, forecast to 2025.
3.4 Academic research
4 ANTIVIRAL AND ANTIMICROBIAL COATINGS AND SURFACES
4.1 Nanotechnology and nanomaterials solutions
4.1.3 Anti-viral nanoparticles and nanocoatings
126.96.36.199 Reusable Personal Protective Equipment (PPE)
188.8.131.52 Wipe on coatings
4.1.4 Graphene-based coatings
184.108.40.206 Graphene oxide.
220.127.116.11 Reduced graphene oxide (rGO)
18.104.22.168 Markets and applications
4.1.5 Silicon dioxide/silica nanoparticles (Nano-SiO2) -based coatings
22.214.171.124 Antimicrobial and antiviral activity
126.96.36.199 Easy-clean and dirt repellent
4.1.6 Nanosilver-based coatings.
188.8.131.52 Antimicrobial and antiviral activity
184.108.40.206 Markets and applications.
220.127.116.11 Commercial activity
4.1.7 Titanium dioxide nanoparticle-based coatings
18.104.22.168 Exterior and construction glass coatings
22.214.171.124 Outdoor air pollution
126.96.36.199 Interior coatings
188.8.131.52 Medical facilities
184.108.40.206 Wastewater Treatment
220.127.116.11 Antimicrobial coating indoor light activation
4.1.8 Zinc oxide nanoparticle-based coatings
18.104.22.168 Antimicrobial activity
4.1.9 Nanocellullose (cellulose nanofibers and cellulose nanocrystals)-based coatings.
22.214.171.124 Antimicrobial activity
4.1.10 Carbon nanotube-based coatings
126.96.36.199 Antimicrobial activity
4.1.11 Fullerene-based coatings
188.8.131.52 Antimicrobial activity
4.1.12 Chitosan nanoparticle-based coatings
184.108.40.206 Wound dressings
220.127.116.11 Packaging coatings and films
18.104.22.168 Food storage
4.1.13 Copper nanoparticle-based coatings
22.214.171.124 Application in antimicrobial nanocoatings
4.2 Market revenues
4.2.1 Market revenues adjusted to pandemic demand, forecast to 2030.
4.4 Academic research
5 AIR-BORNE VIRUS FILTRATION
5.1 Nanotechnology and nanomaterials solutions (nanoparticles titanium dioxide, Polymeric nanofibers, Nanosilver, Nanocellulose, Graphene, Carbon nanotubes)
5.2 Market revenues
5.2.1 Market estimates adjusted to pandemic demand, forecast to 2025
5.4 Academic research
6 FACEMASKS AND OTHER PPE
6.1 Nanotechnology and nanomaterials solutions (Polymer nanofibers, Nanocellulose, Nanosilver, Graphene)
6.2 Market revenues
6.2.1 Market estimates adjusted to pandemic demand, forecast to 2025
6.4 Academic research
7 DRUG DELIVERY AND THERAPEUTICS
7.1 Nanotechnology and nanomaterials solutions
7.2 Market revenues
7.2.1 Market estimates adjusted to pandemic demand, forecast to 2025
7.4 Academic research
List of Tables
Table 1. Current Diagnostic Tests for COVID-19
Table 2. Development phases of diagnostic tests
Table 3. Emerging Diagnostic Tests for COVID-19
Table 4. Nanoparticles for diagnostic testing-Types of nanoparticles, properties and application
Table 5. Gold nanoparticle reagent suppliers list
Table 6. Carbon nanomaterials for diagnostic testing-types, properties and applications
Table 7. Global revenues for nanotech-based diagnostics and testing, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 8. Academic research in nano-based COVID-19 diagnostics and testing.
Table 9: Anti-microbial and antiviral nanocoatings-Nanomaterials used, principles, properties and applications.
Table 10. Nanomaterials utilized in antimicrobial and antiviral nanocoatings coatings-benefits and applications.
Table 11: Properties of nanocoatings.
Table 12: Antimicrobial and antiviral nanocoatings markets and applications
Table 13: Nanomaterials used in nanocoatings and applications.
Table 14: Graphene properties relevant to application in coatings
Table 15. Bactericidal characters of graphene-based materials
Table 16. Markets and applications for antimicrobial and antiviral nanocoatings graphene nanocoatings
Table 17. Markets and applications for antimicrobial and antiviral nanosilver coatings.
Table 18. Commercial activity in antimicrobial nanosilver nanocoatings
Table 19. Antibacterial effects of ZnO NPs in different bacterial species.
Table 20. Types of carbon-based nanoparticles as antimicrobial agent, their mechanisms of action and characteristics
Table 21. Mechanism of chitosan antimicrobial action
Table 22. Global revenues for antimicrobial and antiviral nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates.
Table 23. Global revenues for Anti-fouling & easy clean nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates.
Table 24. Global revenues for self-cleaning (bionic) nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 25. Global revenues for self-cleaning (photocatalytic) nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 26. Antimicrobial, antiviral and antifungal nanocoatings research in academia
Table 27. Cellulose nanofibers (CNF) membranes
Table 28: Comparison of CNT membranes with other membrane technologies
Table 29. Nanomaterials in air-borne virus filtration-properties and applications
Table 30. Global revenues for nanotech-based air-borne virus filtration, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 31: Oji Holdings CNF products
Table 32. Academic research in nano-based air-borne virus filtration
Table 33. Nanomaterials in facemasks and other PPE-properties and applications
Table 34. Global revenues for nanotech-based facemasks and PPE, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 35. Academic research in nano-based facemasks and other PPE
Table 36. Applications in drug delivery and therapeutics, by nanomaterials type-properties and applications
Table 37. Nanotechnology drug products
Table 38. List of antigens delivered by using different nanocarriers
Table 39. Nanoparticle-based vaccines
Table 40. Global revenues for nano-based drug delivery and therapeutics, 2019-2030, billion US$, adjusted for COVID-19 related demand, conservative and high estimates
Table 41. Academic research in nano-based drug delivery and therapeutics to address COVD-19
List of Figures
Figure 1. Anatomy of COVID-19 Virus
Figure 2. Graphene-based sensors for health monitoring
Figure 3. Schematic of COVID-19 FET sensor incorporating graphene
Figure 4. Global revenues for nanotech-based diagnostics and testing, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 5. Printed graphene biosensors
Figure 6. AGILE R100 system
Figure 7. nano-screenMAG particles
Figure 8. GFET sensors.
Figure 9. DNA endonuclease-targeted CRISPR trans reporter (DETECTR) system
Figure 10. SGTi-flex COVID-19 IgM/IgG
Figure 11. Schematic of anti-viral coating using nano-actives for inactivation of any adhered virus on the surfaces
Figure 12: Graphair membrane coating
Figure 13: Antimicrobial activity of Graphene oxide (GO)
Figure 14. Nano-coated self-cleaning touchscreen
Figure 15: Hydrophobic easy-to-clean coating
Figure 16 Anti-bacterial mechanism of silver nanoparticle coating.
Figure 17: Mechanism of photocatalysis on a surface treated with TiO2 nanoparticles
Figure 18: Schematic showing the self-cleaning phenomena on superhydrophilic surface.
Figure 19: Titanium dioxide-coated glass (left) and ordinary glass (right).
Figure 20: Self-Cleaning mechanism utilizing photooxidation.
Figure 21: Schematic of photocatalytic air purifying pavement.
Figure 22: Schematic of photocatalytic water purification
Figure 23. Schematic of antibacterial activity of ZnO NPs
Figure 24: Types of nanocellulose
Figure 25. Mechanism of antimicrobial activity of carbon nanotubes
Figure 26: Fullerene schematic
Figure 27. TEM images of Burkholderia seminalis treated with (a, c) buffer (control) and (b, d) 2.0 mg/mL chitosan; (A: additional layer; B: membrane damage)
Figure 28. Global revenues for antimicrobial and antiviral nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 29. Global revenues for anti-fouling and easy-to-clean nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 30. Global revenues for self-cleaning (bionic) nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 31. Global revenues for self-cleaning (photocatalytic) nanocoatings, 2019-2030, US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 32. Lab tests on DSP coatings
Figure 33. GrapheneCA anti-bacterial and anti-viral coating
Figure 34. Microlyte® Matrix bandage for surgical wounds
Figure 35. Self-cleaning nanocoating applied to face masks.
Figure 36. NanoSeptic surfaces.
Figure 37. NascNanoTechnology personnel shown applying MEDICOAT to airport luggage carts
Figure 38. Basic principle of photocatalyst TiO2
Figure 39. Schematic of photocatalytic indoor air purification filter.
Figure 40. Global revenues for nanotech-based air-borne virus filtration, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates.
Figure 41. Multi-layered cross section of CNF-nw
Figure 42: Properties of Asahi Kasei cellulose nanofiber nonwoven fabric
Figure 43: CNF nonwoven fabric
Figure 44: CNF gel..
Figure 45. CNF clear sheets
Figure 46. Graphene anti-smog mask
Figure 47. Global revenues for nanotech-based facemasks and PPE, 2019-2030, millions US$, adjusted for COVID-19 related demand, conservative and high estimates
Figure 48. FNM’s nanofiber-based respiratory face mask..
Figure 49. ReSpimask® mask
Figure 50. Schematic of different nanoparticles used for intranasal vaccination
Figure 51. Global revenues for nano-based drug delivery and therapeutics, 2019-2030, billion US$, adjusted for COVID-19 related demand, conservative and high estimates.
So are you ready for your first “printed graphene bio-sensors”? Just picked a random item from the list above.
So what I’m going to do in the upcoming updates to this article is to follow every lead I got above, and I’m going to investigate every company they report on, as per their list below. You should do it too, independently, and compare your results with mine. It’s both science and investigative journalism, the juiciest combo.
- Abbott Laboratories
- Advanced Materials-JTJ s.r.o.
- Arbutus Biopharma
- Arcturus Therapeutics
- Bio-Gate AG
- BlueWillow Biologics
- Covalon Technologies Ltd.
- Daicel FineChem Ltd.
- Elastrin Therapeutics Inc.
- EnGeneIC Ltd.
- Ferrotec (USA) Corporation
- G6 Materials
- Grolltex, Inc.
- Luminex Corporation
- Nano Came Co. Ltd.
- NanoTouch Materials, LLC
- NANOVIA s.r.o.
- RESPILON Group s. r. o.
- Sonovia Ltd.
- TECH LLC
- Toray Industries
- Tortech Nano Fibers
So yeah, that’s it for now, and if you think this is not enough to prove much, you can’t be more wrong, you’re probably bathing in dangerous or lethal nanotech as you read this, but feel free to return to this link in the coming days and weeks, I will be adding more evidence as I dig it out. I have about 100 leads there, it’s going to be a long process, friends!
Until then please read this:
A taste of the future: Luminex, on of the companies listed above, makes PCR tests and stuff like magnetic micro-beads. They’ve just been bought for almost $2B by some Italians who can afford $1000+ books.